| | |
CD4T count (cells/mm3)
|
VL (log copies/ml)
|
|---|
|
Patient ID
|
Experiment
|
BL
|
M3
|
M6
|
M9
|
BL
|
M3
|
M6
|
M9
|
|---|
|
HA 01
|
MAS
|
239
|
373
|
407
|
502
|
4.61
|
2.37
|
< 1.70
|
< 1.70
|
|
HA 02
|
MAS
|
153
|
222
|
353
|
263
|
5.36
|
1.75
|
1.85
|
< 1.70
|
|
HA 03
|
MAS
|
193
|
441
|
446
|
437
|
5.36
|
2.84
|
1.72
|
2.05
|
|
HA 04
|
MAS
|
273
|
608
|
577
|
761
|
4.58
|
< 1.70
|
< 1.70
|
< 1.70
|
|
HA 05
|
MAS
|
548
|
592
|
956
|
778
|
4.88
|
2.12
|
< 1.70
|
< 1.70
|
|
HA 06
|
MAS
|
239
|
317
|
348
|
591
|
5.01
|
< 2.60
|
< 1.70
|
< 1.70
|
|
HA 07
|
MAS
|
165
|
209
|
282
|
222
|
5.13
|
< 2.60
|
< 2.60
|
< 1.70
|
|
HA 08
|
MAS
|
146
|
241
|
264
|
315
|
4.48
|
< 1.70
|
< 1.70
|
< 1.70
|
|
HA 09
|
MAS
|
205
|
ND
|
400
|
318
|
5.45
|
ND
|
< 1.70
|
< 1.70
|
|
HA 10
|
MAS
|
269
|
327
|
451
|
372
|
5.26
|
< 1.70
|
< 1.70
|
< 1.70
|
|
HA 11
|
MAS
|
324
|
707
|
561
|
590
|
5.68
|
3.26
|
< 2.60
|
< 2.60
|
|
HA 12
|
MAS
|
202
|
245
|
254
|
242
|
5.16
|
< 1.70
|
< 1.70
|
< 1.70
|
|
HA 13
|
MAS
|
261
|
ND
|
425
|
432
|
5.77
|
ND
|
< 1.70
|
< 1.70
|
|
HA 14
|
MAS
|
318
|
257
|
270
|
338
|
5.14
|
< 1.70
|
< 1.70
|
< 1.70
|
|
HA 15
|
MAS
|
258
|
524
|
462
|
300
|
4.57
|
2.35
|
< 1.70
|
< 1.70
|
|
HA 16
|
MAS
|
232
|
356
|
358
|
318
|
5.57
|
< 2.60
|
3.85
|
< 1.70
|
- MAS: custom Macrophage Activation State array platform; CL: commercial CodeLink HWG bioarray platform; CD4T: CD4+ T lymphocyte; VL: viral load; BL: baseline; M3/6/9: sample taken resp. 3, 6 and 9 months after therapy initiation; ND: not done.
